Last reviewed · How we verify
Sinusitis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Doxycyclin · Bulovka Hospital
- Metacillin · Bristol-Myers Squibb
- Unasyn · Bristol-Myers Squibb
- Methocillin S · GSK
- Abelcet · Astellas Pharma
- Demethylchlortetracycline · Pfizer
- Meclan · Johnson And Johnson
- Carampicillin
- Geninax
- Minocycline Hydrochloride · Rempex
MINOCYCLINE works by inhibiting protein synthesis in bacteria, ultimately leading to their death. - Vibramycin · Generic (originally Pfizer)
- Bactocill In Plastic Container · Apothecon
- Minocyclin · University of Southern California
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Sinusitis patent landscape — cliff calendar, originator estates, attackable patents
- Sinusitis treatment landscape brief
- Sinusitis treatment updates RSS
Frequently asked questions about Sinusitis
What drugs treat Sinusitis?
Tracked treatments include Ramycin, Doxycyclin, Metacillin, Unasyn, Methocillin S, Abelcet, Demethylchlortetracycline, Meclan.
What is the treatment for Sinusitis?
Standard treatment for Sinusitis includes Ramycin, Doxycyclin, Metacillin, Unasyn, Methocillin S. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Sinusitis patent cliff · Sinusitis CI report
- Treatment: Ramycin
- Treatment: Doxycyclin · Bulovka Hospital
- Treatment: Metacillin · Bristol-Myers Squibb
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: Methocillin S · GSK
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing